The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease
- 3 April 2020
- journal article
- research article
- Published by IOS Press in Journal of Parkinson's Disease
- Vol. 10 (2), 523-542
- https://doi.org/10.3233/JPD-191768
Abstract
Background: Parkinson’s disease (PD) is a progressive neurodegenerative disease for which there is no cure. In a clinical trial, the glucagon-like peptide-1 (GLP-1) receptor agonist exendin-4 has shown good protective effects in PD patients. The hormKeywords
This publication has 70 references indexed in Scilit:
- Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7Online Journal of Public Health Informatics, 2013
- Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseasesJournal of Neural Transmission, 2012
- The Beclin 1 network regulates autophagy and apoptosisCell Death & Differentiation, 2011
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's diseaseJournal of Endocrinology, 2009
- Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survivalJournal of Neurochemistry, 2009
- Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's diseaseBrain Research, 2008
- Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's diseaseJournal of Neuroinflammation, 2008
- Glucose-Dependent Insulinotropic Polypeptide-Mediated Up-Regulation of β-Cell Antiapoptotic Bcl-2 Gene Expression Is Coordinated by Cyclic AMP (cAMP) Response Element Binding Protein (CREB) and cAMP-Responsive CREB Coactivator 2Molecular and Cellular Biology, 2008
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006